Later the same year, Nangalia et al. showed that seven of 10 JAK2-first patients presented with PV and six of 6 DNMT3A-first patients with ET, however, they found no association between DNMT3A-first and age or thrombotic risk [133]. The gene discussed is DNMT3A; the disease is essential thrombocythemia.